(19)
(11) EP 4 739 703 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24746875.4

(22) Date of filing: 02.07.2024
(51) International Patent Classification (IPC): 
C07K 16/00(2006.01)
C07K 16/46(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 2317/526; C07K 2317/31; C07K 2317/524; C07K 2317/60; C07K 2317/52; C07K 16/2827; C07K 16/2809; C07K 16/2878; C07K 16/00; C07K 16/468
(86) International application number:
PCT/US2024/036568
(87) International publication number:
WO 2025/010272 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.07.2023 US 202363511726 P

(71) Applicants:
  • NeoImmuneTech, Inc.
    Rockville, MD 20850 (US)
  • Postech Academy-Industry Foundation
    Gyeongsangbuk-do 37673 (KR)

(72) Inventors:
  • IM, Sunkyoung
    Pohang-si Gyeongsangbuk-do (KR)
  • LEE, Minji
    Pohang-si Gyeongsangbuk-do (KR)
  • CHOI, Donghoon
    Seongnam-si Gyeonggi-do (KR)
  • YU, Taekyung
    Busan (KR)
  • LEE, Jie-Oh
    Pohang-si Gyeongsangbuk-do (KR)
  • JEONG, Hye Jin
    Pohang-si Gyeongsangbuk-do 37673 (KR)
  • CHO, Geun Young
    Pohang-si Gyeongsangbuk-do 37673 (KR)

(74) Representative: Mathys & Squire 
32 London Bridge Street The Shard
London SE1 9SG
London SE1 9SG (GB)

   


(54) HETERODIMERIC FC MOLECULES AND USES THEREOF